58110-73-9 Usage
General Description
NSC80665, also known as 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid, is a chemical compound that is commonly used as a fluorescent probe for detecting and measuring the presence of reactive oxygen species (ROS) in biological systems. It is a water-soluble, non-fluorescent compound that becomes highly fluorescent upon reaction with ROS, making it a valuable tool for studying oxidative stress and redox signaling in cells. NSC80665 has also been investigated for its potential as a therapeutic agent for diseases associated with oxidative stress, such as cardiovascular disease and cancer. Additionally, it has been used as a fluorescent tracer in various biochemical and environmental studies due to its sensitivity and selectivity for ROS detection. Overall, NSC80665 is a versatile and important chemical tool for research in the fields of biochemistry, cell biology, and environmental science.
Check Digit Verification of cas no
The CAS Registry Mumber 58110-73-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,1,1 and 0 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 58110-73:
(7*5)+(6*8)+(5*1)+(4*1)+(3*0)+(2*7)+(1*3)=109
109 % 10 = 9
So 58110-73-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H21N3O/c10-2-1-3-11-4-6-12(7-5-11)8-9-13/h13H,1-10H2
58110-73-9Relevant articles and documents
TRITERPENE AMINE DERIVATIVES
-
Paragraph 00428; 0431-00432; 00435-00436, (2020/01/24)
The present invention concerns novel pharmaceutically active triterpene amine derivatives, pharmaceutical compositions containing the same, their use as medicaments, and the use of the compounds for the manufacture of specific medicaments. The present invention also concerns a method of treatment involving administration of the triterpene amine compounds. Specifically, the compounds are derivatives of betulinic acid having substitutions at one or more of the C-3, C-28 and C-19 positions as further described herein. The novel compounds are useful as antiretroviral agents. In particular, the novel compounds are useful for the treatment of Human Immunodeficiency Virus-1 (HIV-1).
